{"id":"imported-compared-vaccine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reaction (pain, redness, swelling)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a vaccine, it contains antigens (either live attenuated, inactivated, or recombinant) that train the immune system to recognize and respond to specific pathogens. The exact mechanism depends on the vaccine type and target pathogen, but generally involves activation of both humoral (antibody) and cellular (T-cell) immunity to confer protective immunity against infection.","oneSentence":"This is an imported vaccine product that stimulates the immune system to prevent infectious disease through antigen presentation and adaptive immune response activation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:48:22.754Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of infectious disease (specific indication unknown without product specification)"}]},"trialDetails":[{"nctId":"NCT05421611","phase":"PHASE3","title":"A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2023-05-11","conditions":"Yellow Fever","enrollment":1824},{"nctId":"NCT04975178","phase":"PHASE3","title":"Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa","status":"RECRUITING","sponsor":"Biofabri, S.L","startDate":"2022-10-17","conditions":"Tuberculosis","enrollment":7120},{"nctId":"NCT03777163","phase":"PHASE4","title":"Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2019-04-22","conditions":"Influenza","enrollment":632},{"nctId":"NCT05447377","phase":"PHASE3","title":"A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants","status":"UNKNOWN","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2022-09-16","conditions":"Yellow Fever","enrollment":2216},{"nctId":"NCT03919578","phase":"PHASE2, PHASE3","title":"Protectivity and Safety Following Recombinant Hepatitis B Vaccine","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2019-09-11","conditions":"Immunogenicity","enrollment":536},{"nctId":"NCT01654809","phase":"PHASE4","title":"Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups","status":"COMPLETED","sponsor":"Beijing Center for Disease Control and Prevention","startDate":"2010-08","conditions":"Influenza","enrollment":900}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":248,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"imported compared vaccine","genericName":"imported compared vaccine","companyName":"Beijing Center for Disease Control and Prevention","companyId":"beijing-center-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"This is an imported vaccine product that stimulates the immune system to prevent infectious disease through antigen presentation and adaptive immune response activation. Used for Prevention of infectious disease (specific indication unknown without product specification).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}